Pancreatic Cancer Research

ResearcherSeoul National UniversityNo recent work listed

Hyung Woo Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6305-452X; OpenAlex author ID A5100613136. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: 1 paper

Papers 3

  1. Serum interleukin-6 is associated with pancreatic ductal adenocarcinoma progression pattern. Co-author DOI 10.1097/md.0000000000005926↗
  2. Clinical impact of neoadjuvant treatment in resectable pancreatic cancer: a systematic review and meta-analysis protocol. Co-author DOI 10.1136/bmjopen-2015-010491↗
  3. Initial Metastatic Site as a Prognostic Factor in Patients With Stage IV Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/md.0000000000001012↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jin‐Hyeok Hwang · 3 shared papers, 2015–2017 · strength 0.21
  2. Jaihwan Kim · 3 shared papers, 2015–2017 · strength 0.21
  3. Jong-Chan Lee · 2 shared papers, 2015–2017 · strength 0.14
  4. Jong-chan Lee · 1 shared paper, 2016 · strength 0.07
  5. Yoon Suk Lee · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.